Our study not only elucidates a novel LPA-LPA1 pathway that induces BMSC differentiation into myofibroblasts thereby contributing to lung fibrosis but also provides more evidence for LPA1 as a potential therapeutic target for fibrosis disease treatment. The gene discussed is LPA; the disease is pulmonary fibrosis.